These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11179834)
1. Expressions of cancer-testis antigens in human hepatocellular carcinomas. Chen CH; Chen GJ; Lee HS; Huang GT; Yang PM; Tsai LJ; Chen DS; Sheu JC Cancer Lett; 2001 Mar; 164(2):189-95. PubMed ID: 11179834 [TBL] [Abstract][Full Text] [Related]
2. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma. Lu Y; Wu LQ; Lü ZH; Wang XJ; Yang JY Chin Med J (Engl); 2007 Jun; 120(12):1042-6. PubMed ID: 17637219 [TBL] [Abstract][Full Text] [Related]
3. Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues. Wang XY; Chen HS; Luo S; Zhang HH; Fei R; Cai J Oncol Rep; 2009 Mar; 21(3):713-9. PubMed ID: 19212631 [TBL] [Abstract][Full Text] [Related]
4. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas. Mashino K; Sadanaga N; Tanaka F; Yamaguchi H; Nagashima H; Inoue H; Sugimachi K; Mori M Br J Cancer; 2001 Sep; 85(5):713-20. PubMed ID: 11531257 [TBL] [Abstract][Full Text] [Related]
5. Expression of cancer-testis antigens in hepatocellular carcinoma. Zhao L; Mou DC; Leng XS; Peng JR; Wang WX; Huang L; Li S; Zhu JY World J Gastroenterol; 2004 Jul; 10(14):2034-8. PubMed ID: 15237429 [TBL] [Abstract][Full Text] [Related]
6. [Expression of NY-ESO-1 and LAGE-1 cancer-testis antigens in hepatocellular carcinoma]. Zhang WM; Xiao G; Zhang M; Guo AL; Dong Y; Wen JM Zhonghua Bing Li Xue Za Zhi; 2005 Apr; 34(4):202-5. PubMed ID: 16091172 [TBL] [Abstract][Full Text] [Related]
7. Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma. Riener MO; Wild PJ; Soll C; Knuth A; Jin B; Jungbluth A; Hellerbrand C; Clavien PA; Moch H; Jochum W Int J Cancer; 2009 Jan; 124(2):352-7. PubMed ID: 18942708 [TBL] [Abstract][Full Text] [Related]
8. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma. Nakamura S; Nouso K; Noguchi Y; Higashi T; Ono T; Jungbluth A; Chen YT; Old LJ; Nakayama E; Shiratori Y J Gastroenterol Hepatol; 2006 Aug; 21(8):1281-5. PubMed ID: 16872310 [TBL] [Abstract][Full Text] [Related]
9. Expression of cancer testis genes in human brain tumors. Sahin U; Koslowski M; Türeci O; Eberle T; Zwick C; Romeike B; Moringlane JR; Schwechheimer K; Feiden W; Pfreundschuh M Clin Cancer Res; 2000 Oct; 6(10):3916-22. PubMed ID: 11051238 [TBL] [Abstract][Full Text] [Related]
10. Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters. Peng JR; Chen HS; Mou DC; Cao J; Cong X; Qin LL; Wei L; Leng XS; Wang Y; Chen WF Cancer Lett; 2005 Mar; 219(2):223-32. PubMed ID: 15723723 [TBL] [Abstract][Full Text] [Related]
11. [Expression of tumor-specific cancer/testis antigens in hepatocellular carcinoma]. Chen HS; Qin LL; Cong X; Wang Y; Fei R; Jiang D; Cao J; Su JJ; Wei L; Chen WF; Wang Y Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):145-8. PubMed ID: 12681059 [TBL] [Abstract][Full Text] [Related]
12. [Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma]. Zhang WM; Xiao G; Xie D; Zhang M; Guo AL; Wen JM Ai Zheng; 2005 May; 24(5):622-6. PubMed ID: 15890110 [TBL] [Abstract][Full Text] [Related]
13. Expression of cancer/testis (CT) antigens in lung cancer. Tajima K; Obata Y; Tamaki H; Yoshida M; Chen YT; Scanlan MJ; Old LJ; Kuwano H; Takahashi T; Takahashi T; Mitsudomi T Lung Cancer; 2003 Oct; 42(1):23-33. PubMed ID: 14512184 [TBL] [Abstract][Full Text] [Related]
14. High frequency of expression of MAGE genes in human hepatocellular carcinoma. Chen CH; Huang GT; Lee HS; Yang PM; Yan MD; Chen DS; Sheu JC Liver; 1999 Apr; 19(2):110-4. PubMed ID: 10220740 [TBL] [Abstract][Full Text] [Related]
15. SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs. Taylor BJ; Reiman T; Pittman JA; Keats JJ; de Bruijn DR; Mant MJ; Belch AR; Pilarski LM J Immunother; 2005; 28(6):564-75. PubMed ID: 16224274 [TBL] [Abstract][Full Text] [Related]
16. Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis. Kubuschok B; Xie X; Jesnowski R; Preuss KD; Romeike BF; Neumann F; Regitz E; Pistorius G; Schilling M; Scheunemann P; Izbicki JR; Löhr JM; Pfreundschuh M Int J Cancer; 2004 Apr; 109(4):568-75. PubMed ID: 14991579 [TBL] [Abstract][Full Text] [Related]
17. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma. Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma. Korangy F; Ormandy LA; Bleck JS; Klempnauer J; Wilkens L; Manns MP; Greten TF Clin Cancer Res; 2004 Jul; 10(13):4332-41. PubMed ID: 15240519 [TBL] [Abstract][Full Text] [Related]
19. Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1. Maio M; Coral S; Sigalotti L; Elisei R; Romei C; Rossi G; Cortini E; Colizzi F; Fenzi G; Altomonte M; Pinchera A; Vitale M J Clin Endocrinol Metab; 2003 Feb; 88(2):748-54. PubMed ID: 12574209 [TBL] [Abstract][Full Text] [Related]
20. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1. Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]